Karapınar, B. Et Al. 2012. Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study GroupHyperferritinemia in the critically ill child with secondary HLH/sepsis/MODS/MAS: what is the treatment?. Crit Care , vol.19, no.16 .

Karapınar, B., YILDIZDAŞ, R. D., Demirkol, D., Kendirli, T., Bayrakçı, B., Köroğlu, T., ... Dursun, O.(2012). Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study GroupHyperferritinemia in the critically ill child with secondary HLH/sepsis/MODS/MAS: what is the treatment?. Crit Care , vol.19, no.16.

Karapınar, B Et Al. "Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study GroupHyperferritinemia in the critically ill child with secondary HLH/sepsis/MODS/MAS: what is the treatment?," Crit Care , vol.19, no.16, 2012

Karapınar, B Et Al. "Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study GroupHyperferritinemia in the critically ill child with secondary HLH/sepsis/MODS/MAS: what is the treatment?." Crit Care , vol.19, no.16, 2012

Karapınar, B. Et Al. (2012) . "Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study GroupHyperferritinemia in the critically ill child with secondary HLH/sepsis/MODS/MAS: what is the treatment?." Crit Care , vol.19, no.16.

@article{article, author={B Karapınar Et Al. }, title={Carcillo JA; Turkish Secondary HLH/MAS Critical Care Study GroupHyperferritinemia in the critically ill child with secondary HLH/sepsis/MODS/MAS: what is the treatment?}, journal={Crit Care}, year=2012}